Figure 3. c-Fos expressions in several brain areas after icv administration of nesfatin-1. The number of c-Fos was significantly greater in the group treated with icv nesfatin-1 (0.5 nmol / 5 μl) than in control saline-treated group in the PVN (A,H), SON (B,H), NTS (D,H), LC (E,H), DR (F,H) and MR (G,H), while no difference was observed between two groups in the ARC (C,H). *p < 0.05, **p < 0.01 vs. control.